Citi Bolsters Healthcare M&A with Top Dealmaker Jeff Stute

In a strategic move to strengthen its healthcare mergers and acquisitions (M&A) capabilities, Citigroup (Citi) has hired veteran investment banker Jeff Stute from Perella Weinberg Partners. Stute, who brings over 25 years of experience in healthcare M&A, will join Citi as a vice chair focused on North American healthcare deals. This hire is expected to bolster Citi's market share in the competitive healthcare M&A landscape and drive growth in the sector.

Stute's extensive experience in healthcare M&A, spanning three decades at Perella Weinberg Partners and JPMorgan Chase, brings valuable expertise and relationships to Citi. His track record in advising on large pharmaceutical transactions, such as Receptos' $7.2 billion acquisition by Celgene and Catalent's $16.5 billion sale to Novo Nordisk's parent company, demonstrates his ability to handle complex deals. Stute's leadership roles in North American M&A and global healthcare investment banking further strengthen Citi's healthcare investment banking franchise.


Stute's focus on healthcare mergers in North America aligns with Citi's broader effort to win more market share from rivals and solidify its position in the competitive healthcare M&A landscape. With Stute's addition, Citi aims to increase its market share in healthcare M&A, challenging established competitors like JPMorgan and Goldman Sachs. Stute's deep industry knowledge and client connections, honed during his tenure at JPMorgan, could potentially poach deals from his former employer, further enhancing Citi's competitive position.


Citi's recent promotions in healthcare investment banking, coupled with Stute's hire, position the bank to win more roles on large healthcare transactions. As Big Pharma players shift towards smaller private targets, Citi's strengthened healthcare M&A team can capitalize on the slowdown in pharma dealmaking. Stute's expertise in healthcare M&A, along with Citi's strategic focus on the sector, will enable the bank to better navigate the current market dynamics and generate new revenue streams.

In conclusion, Citi's hire of top dealmaker Jeff Stute from Perella Weinberg Partners is a strategic move that bolsters the bank's healthcare M&A capabilities. Stute's extensive experience, track record, and industry connections position Citi to increase its market share in healthcare M&A and challenge established competitors. As the healthcare sector continues to evolve, Citi's strengthened healthcare M&A team, led by Stute, is well-equipped to capitalize on emerging opportunities and drive growth in the sector.